| Literature DB >> 25478225 |
R S McCulloch1, M S Ashwell2, C Maltecca2, A T O'Nan2, P L Mente3.
Abstract
An impact injury model of early stage osteoarthritis (OA) progression was developed using a mechanical insult to an articular cartilage surface to evaluate differential gene expression changes over time and treatment. Porcine patellae with intact cartilage surfaces were randomized to one of three treatments: nonimpacted control, axial impaction (2000 N), or a shear impaction (500 N axial, with tangential displacement to induce shear forces). After impact, the patellae were returned to culture for 0, 3, 7, or 14 days. At the appropriate time point, RNA was extracted from full-thickness cartilage slices at the impact site. Quantitative real-time PCR was used to evaluate differential gene expression for 18 OA related genes from four categories: cartilage matrix, degradative enzymes and inhibitors, inflammatory response and signaling, and cell apoptosis. The shear impacted specimens were compared to the axial impacted specimens and showed that shear specimens more highly expressed type I collagen (Col1a1) at the early time points. In addition, there was generally elevated expression of degradative enzymes, inflammatory response genes, and apoptosis markers at the early time points. These changes suggest that the more physiologically relevant shear loading may initially be more damaging to the cartilage and induces more repair efforts after loading.Entities:
Year: 2014 PMID: 25478225 PMCID: PMC4248372 DOI: 10.1155/2014/371426
Source DB: PubMed Journal: Arthritis ISSN: 2090-1992
OA related genes. Full gene names, abbreviations, forward and reverse primer sequences, annealing temperatures, amplicon lengths, and NCBI numbers.
| OA Related Genes | |||||
|---|---|---|---|---|---|
| Gene name | Gene abbreviation | Sequence (5′→ 3′) | Annealing temp | Amplicon length | NCBI Number |
|
| |||||
| Collagen, Type I, Alpha 1 |
| F: CAACCGCTTCACCTACAGC | 60 | 101 | AK236626 |
| R: TTTTGTATTCGATCACTGTCTTGCC | |||||
| Collagen, Type II, Alpha 1 |
| F: GAGAGGTCTTCCTGGCAAAG | 60 | 118 | AF201724.1 |
| R: AAGTCCCTGGAAGCCAGAT | |||||
| Aggrecan |
| F: TGCAGGTGACCATGGCC | 60 | 79 | AF201722b |
| R: CGGTAATGGAACACAACCCCT | |||||
| SRY (sex determining gene region Y) box-9 |
| F: CAGGGCTCTGTGCTCTACTCC | 60 | 230 | NM_213843.1 |
| R: GGGTTACGGTCTTTCTTCGGT | |||||
| Osteopontin |
| F: CCGCAGCCAGGAGCAGTC | 55 | 214 | NM_214023.1 |
| R: GTTGATCTCAGAAGACGCACTCTC | |||||
| Cartilage oligometric matrix protein |
| F: GGCTGGAAGGACAAGACATC | 55 | 82 | XM_003123529.1 |
| R: CCTCATAGAACCGCACTCTG | |||||
|
| |||||
|
| |||||
| Matrix metalloprotease-1 |
| F: TGATGGACCTGGAGGAAACC | 59 | 131 | NM_001166229 |
| R: GAGCAGCCACACGATACAAG | |||||
| Matrix metalloprotease-3 |
| F: GATGTTGGTTACTTCAGCAC | 50 | 197 | NM_001166308.1 |
| R: ATCATTATGTCAGCCTCTCC | |||||
| Matrix metalloprotease-13 |
| F: CCAAAGGCTACAACTTGTTTCTTG | 60 | 77 | AF069643 |
| R: TGGGTCCTTGGAGTGGTCAA | |||||
| TIMP metallopeptidase inhibitor-1 |
| F: CCTCGTACCAGCGTTATG | |||
| R: CGTTCCACAGTTGTCCAG | 59 | 177 | NM_213857.1 | ||
| TIMP metallopeptidase inhibitor-2 |
| F: ATATACGAGAACACCAGACC | |||
| R: GGAATGATTACAACGGATGC | 59 | 152 | AK237154.1 | ||
| ADAM metallopeptidase with thrombospondin Type 1 motif 5 |
| F: CGCTGCCACCACACTCAA | 60 | 80 | NM_007038.3 |
|
| |||||
|
| |||||
| Indian hedgehog |
| F: CAGCGGGCGCTATGAAGGCA | 60 | 140 | XM_001925486.1 |
| R: GGTCCTTGCAGCGCTGGGTC | |||||
| Transforming growth factor |
| F: GGAGTGGCTGTCCTTTGATGT | 60 | 117 | NM_214015.1 |
| R: AGTGTGTTATCTTTGCTGTCA | |||||
| Nitric oxide synthase 2, inducible |
| F: TGAATTTGTCAACCTGTATTAC | 53 | 82 | NM_001143690.1 |
| R: CTTTGTTACCGCTTCCAC | |||||
| Chitinase-3-like protein 1 |
| F: TGACGCTCTATGACACAC | 62 | 194 | NM_001001540 |
| R: GGCTAGGTCCAGTCCATC | |||||
|
| |||||
|
| |||||
| Caspase-8 |
| F: TGGGCAAACAGATGCCACAACCT | 60 | 153 | NM_001031779.2 |
| R: CCCCTTCAATCTAGCCCACCCCC | |||||
|
|
| F: TAGAGTTTGTGATGGAGAA | 53 | 107 | NM_213839.1 |
| R: ATTGAGAAGTGTGACAGA | |||||
Differential gene expression for shear compared to axial specimens at each time point. Fold changes are shown on the left, and the corresponding q-values are shown on the right. Significant q-values (q < 0.2) and the associated fold changes are in bold.
| Comparing treatments within time point | ||||||||
|---|---|---|---|---|---|---|---|---|
| Genes grouped by functional type | Fold changes |
| ||||||
| Shear versus axial | Shear versus axial | |||||||
| Day 0 | Day 3 | Day 7 | Day 14 | Day 0 | Day 3 | Day 7 | Day 14 | |
| Cartilage matrix | ||||||||
|
|
|
| 0.54 |
|
|
| 0.43 |
|
|
| 0.55 |
|
| 1.07 | 0.27 |
|
| 0.88 |
|
| 0.66 | 1.15 | 1.21 |
| 0.43 | 0.68 | 0.68 |
|
|
| 0.89 | 1.26 | 1.02 |
| 0.95 | 0.95 | 0.95 |
|
|
| 0.97 | 1.36 | 1.27 | 2.63 | 0.95 | 0.83 | 0.83 | 0.20 |
|
|
| 0.94 | 0.75 | 1.44 |
| 0.84 | 0.51 | 0.51 |
| Degradative enzymes & inhibitors | ||||||||
|
| 2.84 | 1.13 | 0.49 | 0.37 | 0.32 | 0.84 | 0.32 | 0.32 |
|
| 2.36 | 1.62 | 3.19 | 0.56 | 0.45 | 0.50 | 0.41 | 0.50 |
|
|
|
|
| 0.71 |
|
|
| 0.60 |
|
| 1.33 | 0.88 | 0.80 | 1.23 | 0.69 | 0.69 | 0.69 | 0.69 |
|
|
|
| 0.71 | 1.58 |
|
| 0.39 | 0.33 |
|
| 2.02 | 1.49 | 0.82 |
| 0.52 | 0.66 | 0.74 |
|
| Inflammatory response & signaling | ||||||||
|
| 2.00 | 2.73 | 2.25 | 1.68 | 0.30 | 0.30 | 0.30 | 0.36 |
|
|
|
| 0.89 |
|
|
| 0.72 |
|
|
| 0.35 | 1.67 | 0.62 | 2.06 | 0.21 | 0.38 | 0.38 | 0.36 |
|
| 1.08 | 0.54 | 1.05 | 1.61 | 0.92 | 0.57 | 0.92 | 0.57 |
| Cell proliferation & apoptosis | ||||||||
|
| 0.89 | 1.15 | 1.04 |
| 0.91 | 0.91 | 0.91 |
|
|
|
| 0.92 | 1.90 | 1.81 |
| 0.85 | 0.22 | 0.22 |
Figure 1Fold changes for shear versus axial specimens within each time point. Fold change is shown on the vertical axis as a log scale, and days in culture are shown on the horizontal axis. Error bars for fold changes are depicted and significant differences for the respective comparison are indicated with an asterisk (∗). A graph is shown for each gene category: cartilage matrix (a), degradative enzymes (b), inflammatory response (c), and apoptosis (d).
Differential gene expression for shear compared to control specimens at each time point. Fold changes are shown on the left, and the corresponding q-values are shown on the right. Significant q-values (q < 0.2) and the associated fold changes are in bold.
| Comparing treatments within time point | ||||||||
|---|---|---|---|---|---|---|---|---|
| Genes grouped by functional type | Fold changes |
| ||||||
| Shear versus control | Shear versus control | |||||||
| Day 0 | Day 3 | Day 7 | Day 14 | Day 0 | Day 3 | Day 7 | Day 14 | |
| Cartilage matrix | ||||||||
|
| 1.37 |
|
| 0.35 | 0.70 |
|
| 0.24 |
|
| 1.41 | 0.97 | 1.13 | 1.96 | 0.94 | 0.94 | 0.94 | 0.62 |
|
| 0.82 | 1.29 | 1.14 | 1.53 | 0.70 | 0.70 | 0.70 | 0.70 |
|
| 1.00 | 0.71 | 0.62 | 1.33 | 0.99 | 0.56 | 0.56 | 0.56 |
|
| 1.02 | 2.26 | 0.78 | 0.58 | 0.97 | 0.40 | 0.83 | 0.53 |
|
| 0.60 | 0.87 | 0.93 | 0.81 | 0.47 | 0.83 | 0.83 | 0.83 |
| Degradative enzymes & inhibitors | ||||||||
|
| 1.55 | 0.67 | 0.39 |
| 0.60 | 0.60 | 0.25 |
|
|
|
| 0.61 |
|
|
| 0.49 |
|
|
|
| 1.05 |
| 0.54 |
| 0.94 |
| 0.47 |
|
|
| 1.24 | 0.85 | 0.96 | 0.84 | 0.84 | 0.84 | 0.90 | 0.84 |
|
| 0.96 | 1.34 | 0.49 | 1.03 | 0.93 | 0.93 | 0.28 | 0.93 |
|
| 0.52 | 0.87 |
|
| 0.39 | 0.81 |
|
|
| Inflammatory response & signaling | ||||||||
|
| 2.33 | 0.83 | 2.05 | 1.27 | 0.42 | 0.74 | 0.42 | 0.74 |
|
| 0.72 | 1.22 | 0.86 | 0.68 | 0.57 | 0.63 | 0.63 | 0.57 |
|
| 0.77 | 0.92 | 0.94 |
| 0.91 | 0.91 | 0.91 |
|
|
|
|
| 1.20 |
|
|
| 0.69 |
|
| Cell proliferation & apoptosis | ||||||||
|
| 0.98 | 0.70 | 0.63 | 1.31 | 0.95 | 0.58 | 0.58 | 0.58 |
|
|
| 1.20 | 0.84 | 1.45 |
| 0.69 | 0.69 | 0.69 |